Integral Diagnostics Ltd (ASX:IDX)
A$ 2.92 0.05 (1.74%) Market Cap: 1.07 Bil Enterprise Value: 1.38 Bil PE Ratio: 0 PB Ratio: 2.22 GF Score: 85/100

Full Year 2021 Integral Diagnostics Ltd Earnings Call Transcript

Aug 27, 2021 / 12:00AM GMT
Release Date Price: A$4.52 (-15.19%)
Operator

Thank you for standing by, and welcome to the Integral Diagnostics FY '21 Results Call. (Operator Instructions)

I would now like to hand the conference over to Dr. Ian Kadish, CEO and Managing Director. Please go ahead.

Ian Kadish
Integral Diagnostics Limited - CEO, MD & Director

Thank you, Melanie. My name is Ian Kadish. I'm the CEO and Managing Director of Integral Diagnostics. I'm joined here this morning by Anne Lockwood, who's our Chief Financial and Commercial Officer. It's our privilege this morning to present to you another strong set of results from Integral Diagnostics, thanks to the hard work and efforts of 1,524 doctors and staff across our business during some challenging times.

Our vision at IDX is to build a healthier world, and we delivered this by delivering the best health outcome we can for our patients, one patient at a time. We believe in putting our patients first always in demonstrating medical leadership, ensuring that everyone counts, delivering value for our shareholders and for all stakeholders and embracing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot